FDA Inspection
DSC Laboratories, Inc.DSC Laboratories, Inc. – FDA Inspection, Aug 31, 2012
Record Details
This FDA Inspection record concerns DSC Laboratories, Inc., with an inspection on August 31, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- DSC Laboratories, Inc.
- Inspection Date
- August 31, 2012
- Product Type
- Drugs
View Company Profile
ID · 6ee1dda1-c6ae-4d36-93ea-53af12978147
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 797219
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.188Prepared for each batch, include complete information
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
Full citation text and observation details available on the Dashboard.
Other FDA inspections of DSC Laboratories, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 16, 2025 | VAI | Detroit District Office | Drug Quality Assurance |
| October 11, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 25, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 27, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 13, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for DSC Laboratories, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.